Literature DB >> 35165826

Generation of NPHP1 knockout human pluripotent stem cells by a practical biallelic gene deletion strategy using CRISPR/Cas9 and ssODN.

Yuta Nakano1, Koichiro Susa2, Tomoki Yanagi1, Yuichi Hiraoka3,4, Takefumi Suzuki1, Takayasu Mori1, Fumiaki Ando1, Shintaro Mandai1, Tamami Fujiki1, Tatemitsu Rai1, Shinichi Uchida1, Eisei Sohara1.   

Abstract

CRISPR/Cas9 genome editing underwent remarkable progress and significantly contributed to the development of life sciences. Induced pluripotent stem cells (iPSCs) have also made a relevant contribution to regenerative medicine, pharmacological research, and genetic disease analysis. However, knockout iPSC generation with CRISPR/Cas9 in general has been difficult to achieve using approaches such as frameshift mutations to reproduce genetic diseases with full-length or nearly full-length gene deletions. Moreover, splicing and illegitimate translation could make complete knockouts difficult. Full-length gene deletion methods in iPSCs might solve these problems, although no such approach has been reported yet. In this study, we present a practical two-step gene-editing strategy leading to the precise, biallelic, and complete deletion of the full-length NPHP1 gene in iPSCs, which is the first report of biallelic (compound heterozygous) full-gene deletion in iPSCs using CRISPR/Cas9 and single-stranded oligodeoxynucleotides mainly via single-strand template repair (SSTR). Our strategy requires no selection or substances to enhance SSTR and can be used for the analysis of genetic disorders that are difficult to reproduce by conventional knockout methods.
© 2022. The Society for In Vitro Biology.

Entities:  

Keywords:  CRISPR/Cas9; Complete gene deletion; Gene editing; Nephrocystin-1; iPSCs

Mesh:

Substances:

Year:  2022        PMID: 35165826     DOI: 10.1007/s11626-022-00655-0

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  41 in total

1.  Generation of two human induced pluripotent stem cell lines derived from two juvenile nephronophthisis patients with NPHP1 deletion.

Authors:  Yutaka Arai; Miho Takami; Yuri An; Mami Matsuo-Takasaki; Yasuko Hemmi; Tamami Wakabayashi; Jun Inoue; Michiya Noguchi; Yukio Nakamura; Keisuke Sugimoto; Tsukasa Takemura; Keisuke Okita; Kenji Osafune; Minoru Takasato; Tadayoshi Hayata; Yohei Hayashi
Journal:  Stem Cell Res       Date:  2020-04-21       Impact factor: 2.020

Review 2.  Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9.

Authors:  Ronen Ben Jehuda; Yuval Shemer; Ofer Binah
Journal:  Stem Cell Rev Rep       Date:  2018-06       Impact factor: 5.739

3.  Genotype-phenotype correlation in 440 patients with NPHP-related ciliopathies.

Authors:  Moumita Chaki; Julia Hoefele; Susan J Allen; Gokul Ramaswami; Sabine Janssen; Carsten Bergmann; John R Heckenlively; Edgar A Otto; Friedhelm Hildebrandt
Journal:  Kidney Int       Date:  2011-08-24       Impact factor: 10.612

4.  Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells.

Authors:  Van Trung Chu; Timm Weber; Benedikt Wefers; Wolfgang Wurst; Sandrine Sander; Klaus Rajewsky; Ralf Kühn
Journal:  Nat Biotechnol       Date:  2015-03-24       Impact factor: 54.908

5.  Activation of the renal Na+:Cl- cotransporter by angiotensin II is a WNK4-dependent process.

Authors:  María Castañeda-Bueno; Luz Graciela Cervantes-Pérez; Norma Vázquez; Norma Uribe; Sheila Kantesaria; Luciana Morla; Norma A Bobadilla; Alain Doucet; Dario R Alessi; Gerardo Gamba
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-01       Impact factor: 11.205

6.  Differential requirement of NPHP1 for compartmentalized protein localization during photoreceptor outer segment development and maintenance.

Authors:  Poppy Datta; J Thomas Cribbs; Seongjin Seo
Journal:  PLoS One       Date:  2021-05-07       Impact factor: 3.240

7.  An Efficient Electroporation Protocol for the Genetic Modification of Mammalian Cells.

Authors:  Leonardo Chicaybam; Camila Barcelos; Barbara Peixoto; Mayra Carneiro; Cintia Gomez Limia; Patrícia Redondo; Carla Lira; Flávio Paraguassú-Braga; Zilton Farias Meira De Vasconcelos; Luciana Barros; Martin Hernán Bonamino
Journal:  Front Bioeng Biotechnol       Date:  2017-01-23

8.  NPHP1 gene-associated nephronophthisis is associated with an occult retinopathy.

Authors:  Johannes Birtel; Georg Spital; Marius Book; Sandra Habbig; Sören Bäumner; Vera Riehmer; Bodo B Beck; David Rosenkranz; Hanno J Bolz; Mareike Dahmer-Heath; Philipp Herrmann; Jens König; Peter Charbel Issa
Journal:  Kidney Int       Date:  2021-06-19       Impact factor: 10.612

9.  CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens.

Authors:  Jean-Paul Concordet; Maximilian Haeussler
Journal:  Nucleic Acids Res       Date:  2018-07-02       Impact factor: 16.971

10.  Translational outcomes in a full gene deletion of ubiquitin protein ligase E3A rat model of Angelman syndrome.

Authors:  E L Berg; M C Pride; S P Petkova; R D Lee; N A Copping; Y Shen; A Adhikari; T A Fenton; L R Pedersen; L S Noakes; B J Nieman; J P Lerch; S Harris; H A Born; M M Peters; P Deng; D L Cameron; K D Fink; U Beitnere; H O'Geen; A E Anderson; S V Dindot; K R Nash; E J Weeber; M Wöhr; J Ellegood; D J Segal; J L Silverman
Journal:  Transl Psychiatry       Date:  2020-01-27       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.